Literature DB >> 19174249

Supra-aortic vessels aneurysms: diagnosis and prompt intervention.

Marcelo Cury1, Roy K Greenberg, Jose P Morales, Walid Mohabbat, Adrian V Hernandez.   

Abstract

PURPOSE: Aneurysms involving the supra-aortic vessels are rare but carry serious risk of embolization, thrombosis, and rupture. We describe our experience with the diagnosis, treatment strategies, and outcomes in patients with extended follow-up.
METHODS: Data during a 17-year period (January 1990 to December 2007) was analyzed. We assessed age, gender, presenting symptoms, localization, pathologic diagnosis, type of procedures, complications, and survival.
RESULTS: A total of 74 patients were treated for supra-aortic aneurysms. Of all aneurysms treated, 63% were degenerative, 24% iatrogenic, 8% traumatic, 3% genetic, and 1% mycotic. The subclavian artery was most commonly affected (50%, 2/3 in the right side), followed by the common carotid (36%), internal carotid (10%), innominate (3%), and vertebral (1%). At the time of diagnosis, 52 patients (70%) were asymptomatic, but of those symptomatic 68% had an embolic event as a presenting symptom. Embolic episodes were more common in patients with smaller aneurysms (P < .006). Open surgery was performed in 77% of all cases, and the use of endovascular techniques became the predominant treatment modality over the last 4 years. Survival at 30 days was 100%. Five- and 10-year survival rates were 87% and 43%, respectively.
CONCLUSION: Most cases of supra-aortic aneurysm are asymptomatic and embolization as opposed to rupture represents the greatest risk to the patient. Most cases can be detected prior to symptoms. Endovascular repair is an emerging alternative of treatment and, with the current development of appropriate devices, will likely form the mainstay of therapy in the near future.

Entities:  

Mesh:

Year:  2009        PMID: 19174249     DOI: 10.1016/j.jvs.2008.08.088

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Traumatic Aneurysm of Innominate Artery Resulting in Tracheal Stenosis and Rapidly Progressive Respiratory Failure; A Case Report and Literature Review.

Authors:  Hossein Hodjati; Parviz Mardani; Masoud Mousavi; Ahmad Hoseinzadeh; Sajjad Ahmadi; Sahar Sohrabi; Alireza Golchini
Journal:  Bull Emerg Trauma       Date:  2015-07

2.  Isolated dissecting aneurysm of the brachiocephalic artery associated with contained rupture.

Authors:  Tomoaki Hirose; Nobuoki Tabayashi; Yoshiro Yoshikawa; Takehisa Abe; Hiroshi Naito; Yoshihiro Hayata; Keigo Yamashita; Shigeki Taniguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

Review 3.  Giant extracranial aneurysm of the internal carotid artery in neurofibromatosis type 1. A case report and review of the literature.

Authors:  C Moratti; T Andersson
Journal:  Interv Neuroradiol       Date:  2012-09-10       Impact factor: 1.610

4.  Innominate artery aneurysm, how to solve it?

Authors:  Xiao-Long Wang; Xin-Liang Guan; Wen-Jian Jiang; Ou Liu; Hong-Jia Zhang
Journal:  J Int Med Res       Date:  2017-05-28       Impact factor: 1.671

5.  Hybrid Repair of an Aneurysm of the Innominate Artery.

Authors:  Peter-Jan Vancoillie; Karen Peeters; Sigi Nauwelaers; Luc Stockx; Geert Lauwers
Journal:  EJVES Vasc Forum       Date:  2021-10-08

Review 6.  Surgical treatment of innominate artery and aortic aneurysm: a case report and review of the literature.

Authors:  Erdinc Soylu; Leanne Harling; Hutan Ashrafian; Vania Anagnostakou; Dimitris Tassopoulos; Christos Charitos; John Kokotsakis; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2013-06-01       Impact factor: 1.637

7.  Innominate truncal and arch blowout with left hemiparesis and right hemothorax followed by delayed cheese-wire perforation of innominate graft.

Authors:  Pankaj Kaul; Rodolfo Paniagua
Journal:  J Cardiothorac Surg       Date:  2013-04-23       Impact factor: 1.637

8.  Extracranial Vertebral Artery Aneurysm Rupture Complicated by Extrapleural Haematoma.

Authors:  D Nenadic; M Balevic; M Milojevic; S Tanskovic
Journal:  EJVES Short Rep       Date:  2018-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.